Drug recall · November 6, 2019
Lyophilized Chorionic Gonadotropin 11 recall
Why: Lack of Sterility Assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
- Lots / codes
Lot #: INX 530 Exp. 11/6/19; INX 535 Exp. 11/15/19; INX 540 Exp. 2/1/20; INX 545 Exp. 2/15/20; INX 550 Exp. 3/9/20; INX 555 Exp. 3/26/20; INX 560 Exp. 5/3/20; INX 565 Exp. 5/18/20; INX 570 Exp. 6/28/20; INX 575 Exp. 7/18/20
- Quantity
- 3905 vials
- Company
- Innoveix Pharmaceuticals Inc, Addison, TX
- Distribution
- Nationwide within the United States
- Initiated
- October 10, 2019 · Voluntary: Firm initiated
- Classified
- October 28, 2019
- Reported
- November 6, 2019
- Ended
- January 14, 2022
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Chorionic gonadotropin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.